Trends in Inter Partes Review of Life Sciences Patents

Trends in Inter Partes Review of Life Sciences Patents

Publication

Bloomberg BNA's Patent, Trademark & Copyright Journal published an article written by Monica Grewal, James Hill and Kathryn Zalewski, which provides a statistical analysis of inter partes review proceedings before the Patent Trial and Appeal Board and shows that it is not a ''death squad'' for patents.

First available in September 2012 under the America Invents Act, petitions for inter partes review have become a popular and relatively inexpensive staple in patent litigation. Read the full article

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.